ClearBridge LLC (Maryland)’s Vertex Pharmaceuticals VRTX Stock Holding History

ClearBridge LLC (Maryland)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-420	Closed	-$81K	–	100
2018 Q3	$81K	Sell	420 -45	-10%	-$8.01K	0.02%	69
2018 Q2	$79K	Buy	465 +45	+11%	+$6.97K	﹤0.01%	165
2018 Q1	$68K	Hold	420	–	–	﹤0.01%	170
2017 Q4	$63K	Hold	420	–	–	﹤0.01%	170
2017 Q3	$64K	Hold	420	–	–	﹤0.01%	170
2017 Q2	$54K	Sell	420 -230	-35%	-$27.7K	﹤0.01%	170
2017 Q1	$71K	Hold	650	–	–	﹤0.01%	169
2016 Q4	$48K	Hold	650	–	–	﹤0.01%	171
2016 Q3	$57K	Hold	650	–	–	﹤0.01%	172
2016 Q2	$56K	Hold	650	–	–	﹤0.01%	172
2016 Q1	$52K	Hold	650	–	–	﹤0.01%	173
2015 Q4	$82K	Sell	650 -13,900	-96%	-$1.68M	﹤0.01%	170
2015 Q3	$1.51M	Hold	14,550	–	–	0.03%	145
2015 Q2	$1.8M	Buy	14,550 +500	+4%	+$63K	0.03%	145
2015 Q1	$1.66M	Hold	14,050	–	–	0.03%	144
2014 Q4	$1.67M	Hold	14,050	–	–	0.03%	145
2014 Q3	$1.58M	Buy	14,050 +100	+0.7%	+$9.52K	0.03%	143
2014 Q2	$1.32M	Hold	13,950	–	–	0.02%	153
2014 Q1	$987K	Sell	13,950 -6,250	-31%	-$495K	0.02%	148
2013 Q4	$1.5M	Hold	20,200	–	–	0.03%	140
2013 Q3	$1.53M	Sell	20,200 -5,500	-21%	-$438K	0.03%	132
2013 Q2	$2.06M	Buy	+25,700	New	+$1.89M	0.04%	168

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

ClearBridge LLC (Maryland)'s VRTX Position: Q4 2018 in Review

ClearBridge LLC (Maryland) sold out of Vertex Pharmaceuticals (VRTX) in Q4 2018, closing a stake of 420 shares — an estimated $81K sold.

ClearBridge LLC (Maryland) first reported a position in VRTX in Q2 2013 and held it in 22 quarters. The position peaked at $2.06M in Q2 2013. 706 funds tracked by Wall St. Rank hold VRTX as of Q4 2018.

ClearBridge LLC (Maryland) reported no remaining Vertex Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
ClearBridge LLC (Maryland) sold 420 Vertex Pharmaceuticals shares in Q4 2018, an estimated $81K.
ClearBridge LLC (Maryland) first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 22 quarters.
ClearBridge LLC (Maryland)'s Vertex Pharmaceuticals position peaked at $2.06M in Q2 2013.
706 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2018.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q4 2018, filed 14 Feb 2019.